Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis
- PMID: 120383
- DOI: 10.1093/infdis/140.6.873
Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis
Abstract
Clinical isolates of Pseudomonas aeruginosa from patients with cystic fibrosis were studied in an effort to determine the unique characteristics of the infecting strains and to elucidate the pattern of colonization. Of 413 patients studied, 81% were chronically infected with P. aeruginosa. Patients from whom P. aeruginosa was never or only occasionally isolated were in better clinical condition than the chronically infected patients. Isolates were classified into six morphologic varieties: classic, rough, mucoid, gelatinous, dwarf, and enterobacter. Most patients had two or more of these varieties. Such multiple varieties from the same individual were of the same serotype but often differed in antibiotic susceptibility as determined by both the disk and the minimal inhibitory concentration methods. These differences were apparent when mucoid strains were compared with nonmucoid strains and when nonmucoid strains were compared with one another. Studies of antibiotic susceptibility should be performed on each morphologically different type of P. aeruginosa obtained from patients with cystic fibrosis.
Similar articles
-
Pseudomonas aeruginosa in the oral cavity and sputum of patients with cystic fibrosis.Oral Surg Oral Med Oral Pathol. 1985 Jun;59(6):590-4. doi: 10.1016/0030-4220(85)90187-2. Oral Surg Oral Med Oral Pathol. 1985. PMID: 3925406
-
Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.J Chemother. 2010 Dec;22(6):378-83. doi: 10.1179/joc.2010.22.6.378. J Chemother. 2010. PMID: 21303744
-
Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.J Infect Dis. 1976 Aug;134 Suppl:S50-6. doi: 10.1093/infdis/134.supplement_1.s50. J Infect Dis. 1976. PMID: 823279
-
Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):25-30. doi: 10.1007/s10096-005-0076-9. Eur J Clin Microbiol Infect Dis. 2006. PMID: 16402226
-
Clinical aspects of pseudomonas infections.W V Med J. 1981 Dec;77(12):303-10. W V Med J. 1981. PMID: 6797130 Review. No abstract available.
Cited by
-
Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs.Infect Drug Resist. 2015 Jul 29;8:237-47. doi: 10.2147/IDR.S68214. eCollection 2015. Infect Drug Resist. 2015. PMID: 26251621 Free PMC article. Review.
-
Rational parameters for antibiotic therapy in patients with cystic fibrosis.Infection. 1987 Jul-Aug;15(4):300-7. doi: 10.1007/BF01644142. Infection. 1987. PMID: 3117704 Review.
-
Role of an alginate lyase for alginate transport in mucoid Pseudomonas aeruginosa.Infect Immun. 2005 Oct;73(10):6429-36. doi: 10.1128/IAI.73.10.6429-6436.2005. Infect Immun. 2005. PMID: 16177314 Free PMC article.
-
The in vitro activity of ceftazidime against a multi-resistant serotype 12 Pseudomonas aeruginosa.Infection. 1983;11 Suppl 1:S16-9. doi: 10.1007/BF01641099. Infection. 1983. PMID: 6403472
-
Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models.Infect Immun. 2008 May;76(5):1877-88. doi: 10.1128/IAI.01165-07. Epub 2008 Feb 19. Infect Immun. 2008. PMID: 18285499 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical